IMUNITINN® MR is food for special medical purposes based on the green tea, good Lactobacillus Rhamnosus bacteria and vitamin D, for nutrition of persons with weakened immunity, in viral infections, mild and moderate symptoms of flu.
IMUNITINN® MR are three-layer modified release tablets produced by innovative technology enabling gradual release of active substances (epigallocatechin gallate (EGCG) is released over the course of first hour after administration and L. rhamnosus is released in the second hour, while vitamin D is released 4 hours after administration), which enables a triple protection from infections over the course of 24h.
For which conditions is IMUNITINN® MR recommended?
Prevention of viral infections of respiratory tract
Alleviating and treating of flu symptoms
- Immune system stimulation
Prevention of bacterial infection in viral infections
- Adjuvant therapy in treatment of viral, bacterial and fungal infections
Why IMUNITINN® MR?
Prevents the onset and development of viral infection
Proven efficiency in alleviating and elimination of existing flu symptoms
Prevents the recurrent viral, bacterial and fungal infections
Stimulates the immune system activity
Speeds up the recovery after infection
Modified release tablet provides for the triple protection throughout the day
Comfortable administration, 1 tablet a day
What does IMUNITINN® MR contain?
|Active ingredients||1 tablet|
|Dry extract of green tea leaf (Camellia sinesis (L.) Kuntze) standardized at 95% polyphenol and 45% epigallocatechin gallate (EGCG)||444.5 mg||-|
|out of which EGCG||200 mg|
|Lactobacillus Rhamnosus CRL 1505||25 mg (1x109 CFU**)||-|
|Vitamin D (cholecalciferol)||50 μg (2000 IJ)||1000%|
*NRV – nutrient reference value
**CFU = colony forming units, guaranteed at the end of shelf life
How is IMUNITINN® MR used:
Adults: take one tablet a day, with a glass of water on an empty stomach.
10 modified release tablets.